LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Mirae Asset Global Investments Co., Ltd.'s Holding History (CIK: 0001569395)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 9,776 Value ($000) $5 Avg Close — Range —
Q4 2024
Shares 9,305 Value ($000) $6 Avg Close — Range —
Q3 2024
Shares 9,259 Value ($000) $14 Avg Close — Range —
Q2 2024
Shares 7,611 Value ($000) $11 Avg Close — Range —
Q4 2023
Shares 225,506 Value ($000) $437 Avg Close — Range —
Q3 2023
Shares 19,564 Value ($000) $29 Avg Close — Range —
Q2 2023
Shares 16,770 Value ($000) $53 Avg Close — Range —
Q1 2023
Shares 25,336 Value ($000) $60 Avg Close — Range —
Q4 2022
Shares 91,562 Value ($000) $318 Avg Close — Range —
Q3 2022
Shares 91,437 Value ($000) $670 Avg Close — Range —
Q2 2022
Shares 48,427 Value ($000) $316 Avg Close — Range —